Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UnitedHealth (UNH) Counting On Optum For Long-Term Growth

Published 09/21/2016, 05:03 AM
Updated 07/09/2023, 06:31 AM

UnitedHealth Group Inc. (NYSE:UNH) is now banking on its health services business Optum for growth. This decision follows stringent regulatory restrictions imposed by the health care reform in 2010 that hit its health benefits business which provides health insurance products.

Optum is a health services business serving the broad health care marketplace and a major part of the company’s diversification strategy. It incepted from the joining of the company’s health services business into one segment in 2011 and comprises OptumHealth, OptumInsight and OptumRx.
UnitedHealth’s fast growing health services business will fuel long-term growth and be a key differentiator.

Since 2011, Optum has compounded revenues at 23% per year and operating earnings at 34% every year. In 2015, Optum grew its revenues by 42% (including the acquisition of Catamaran in July) and its contract backlog by more than 20%. We expect OptumHealth, OptumInsight and OptumRx to continue producing strong, sustainable growth across the board in 2016 and beyond, as a leader in the U.S. and international health services markets estimated at $1.0 trillion in the aggregate.

The company has grown this segment through a number of acquisitions. Some of the significant takeovers include that of Audax Health Solutions, Inc. in 2014 as well as Irvine-based Monarch HealthCare and care and care management services provider Inspiris in 2011.

In 2015, Optum joined forces with MedExpress, a leader in high quality, affordable walk-in care, to expand access to lower-cost services in communities nationwide. It also acquired AxelaCare Health Solutions, a leading provider of home infusion solutions.

One of the biggest acquisitions made by the company under this segment was that of Catamaan Corp., for $12.8 billion, last year. It bolstered Optum’s pharmacy business.

Management is considering the expansion of the health service business to generate 30–40% of operating income over the longer term and has been making acquisitions in the area. Moreover, management feels that the company is under-penetrated in the health service area and that investments in this field will reap benefits over the long term.

UnitedHealth carries a Zacks Rank #2 (Buy). Other stocks worth considering include The Joint Corp. (NASDAQ:JYNT) , WellCare Health Plans, Inc. (NYSE:WCG) and Nobilis Health Corp. (NYSE:HLTH) . Each of these stocks carries the same Zacks Rank as UnitedHealth. You can see the complete list of today’s Zacks #1 Rank stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



UNITEDHEALTH GP (UNH): Free Stock Analysis Report

WELLCARE HEALTH (WCG): Free Stock Analysis Report

NOBILIS HEALTH (HLTH): Free Stock Analysis Report

JOINT CORP/THE (JYNT): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.